I discovered an exciting new stock for this month’s Special Features Model: Gilead Sciences. Although Gilead is quite well known, many investors are not aware of the vast potential of the company’s new products. To wit: sales more than doubled and earnings per share quadrupled during the first six months of this year—yet Gilead’s price to current earnings multiple is only 17.5!
